Medistim ASA (OSL:MEDI)

Medistim ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	175.63	212.09	179.21	153.87	152.64	129.49
Cash & Short-Term Investments	175.63	212.09	179.21	153.87	152.64	129.49
Cash Growth	11.40%	18.35%	16.47%	0.81%	17.88%	80.12%
Accounts Receivable	116.58	86.39	68.98	74.3	101.66	68.63
Other Receivables	3.09	10.63	10.75	9.94	8.83	4.88
Receivables	119.66	97.02	79.73	84.24	110.49	73.52
Inventory	149.87	161.13	160.52	145.39	114.33	97.41
Prepaid Expenses	-	7.48	5.64	4.67	4.55	6.08
Other Current Assets	-0	0	4.04	3.39	3.88	-
Total Current Assets	445.16	477.72	429.13	391.57	385.89	306.5
Property, Plant & Equipment	72.77	79.39	71.78	57.31	51.31	58.86
Goodwill	-	14.13	14.13	14.13	14.13	14.13
Other Intangible Assets	119.96	71.97	46.59	31.25	21.94	16.04
Long-Term Deferred Tax Assets	-	9.22	9.02	5.14	3.59	3.24
Other Long-Term Assets	-	8.18	4.32	6.33	5.79	4.48
Total Assets	637.88	660.6	574.97	505.72	482.66	403.24

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	-	26.63	17.73	25.08	24.47	13.21
Accrued Expenses	-	45.87	35.95	28.46	32.75	30.82
Current Portion of Leases	-	11.59	9.31	8.38	7.09	7.11
Current Income Taxes Payable	-	42.39	27.38	28.4	25.87	20.33
Other Current Liabilities	140.69	16.73	17.01	3.95	9.64	6.14
Total Current Liabilities	140.69	143.21	107.37	94.28	99.82	77.6
Long-Term Leases	26.24	37.68	25.06	9.26	10.02	17.08
Long-Term Unearned Revenue	15.85	11.31	5.93	4.23	5.13	2.51
Other Long-Term Liabilities	-0	-0	-	-0	-	-0
Total Liabilities	182.77	192.19	138.36	107.78	114.97	97.19

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.59	4.59	4.59	4.59	4.59	4.59
Additional Paid-In Capital	44.17	72.74	67.66	66.6	60.59	55.2
Retained Earnings	-	368.82	328.8	307.38	285.74	240.16
Treasury Stock	-	-0.01	-0.01	-0.01	-0.02	-0.03
Comprehensive Income & Other	406.35	22.28	35.58	19.39	16.8	6.14
Shareholders' Equity	455.11	468.41	436.61	397.94	367.69	306.05
Total Liabilities & Equity	637.88	660.6	574.97	505.72	482.66	403.24

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	26.24	49.27	34.36	17.64	17.11	24.19
Net Cash (Debt)	149.39	162.82	144.85	136.23	135.54	105.3
Net Cash Growth	9.56%	12.41%	6.33%	0.51%	28.72%	221.24%
Net Cash Per Share	-	8.91	7.91	7.45	7.42	5.77
Filing Date Shares Outstanding	-	18.28	18.31	18.28	18.25	18.23
Total Common Shares Outstanding	-	18.28	18.31	18.28	18.25	18.23
Working Capital	304.47	334.51	321.76	297.28	286.07	228.89
Book Value Per Share	-	25.62	23.84	21.77	20.14	16.79
Tangible Book Value	335.15	382.31	375.89	352.57	331.62	275.88
Tangible Book Value Per Share	-	20.91	20.52	19.29	18.17	15.13
Machinery	-	110.6	106.92	103.44	92.98	85.87

Data Source: S&P Global Market Intelligence Last updated: Oct 23, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error